Weight loss drugs, Covid downturn: Pharma had a year full of firsts

Wall Street turned its focus to a handful of newer treatments in different disease areas in 2023, including weight loss medications and a new Alzheimer's drug.

Related Keywords

United States ,Japan ,Americans ,Japanese ,Eli Lilly ,Bristol Myers Squibb ,Novo Nordisk Fiasp ,Chris Viehbacher ,Pfizer ,Boehringer Ingelheim ,Drug Administration ,Amgen ,Johnson ,Astrazeneca ,Novartis ,Glaxosmithkline ,Novo Nordisk ,President Joe Biden ,Inflation Reduction ,Business ,Biotechnology ,Biotech And Pharmaceuticals ,Pharmaceuticals ,Health Care Industry ,Eli Lilly And Co ,Novo Nordiska S ,Biogen Inc ,Pfizer Inc ,Amgen Inc ,Eisai Co Ltd ,Business News ,